In today’s session Metlife Inc (MET) registered an unusually high (225) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the March, 2017 call, expecting serious MET increase. With 225 contracts traded and 7334 open interest for the Mar, 17 contract, it seems this is a quite bullish bet. The option with symbol: MET170317C00050000 closed last at: $0.9 or 25% up. The stock increased 1.13% or $0.5 during the last trading session, hitting $44.87. About 6.23 million shares traded hands. Metlife Inc (NYSE:MET) has risen 6.81% since March 2, 2016 and is uptrending. It has underperformed by 2.43% the S&P500.
Analysts await Metlife Inc (NYSE:MET) to report earnings on November, 2. They expect $1.28 EPS, up 106.45% or $0.66 from last year’s $0.62 per share. MET’s profit will be $1.40 billion for 8.76 P/E if the $1.28 EPS becomes a reality. After $0.83 actual EPS reported by Metlife Inc for the previous quarter, Wall Street now forecasts 54.22% EPS growth.
Metlife Inc (NYSE:MET) Ratings Coverage
Out of 12 analysts covering MetLife (NYSE:MET), 8 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 67% are positive. MetLife has been the topic of 15 analyst reports since July 31, 2015 according to StockzIntelligence Inc. The stock of Metlife Inc (NYSE:MET) has “Hold” rating given on Wednesday, July 13 by Deutsche Bank. The stock of Metlife Inc (NYSE:MET) has “Equal-Weight” rating given on Wednesday, November 11 by Morgan Stanley. The firm earned “Outperform” rating on Friday, September 23 by Wells Fargo. On Thursday, January 14 the stock rating was upgraded by Macquarie Research to “Outperform”. The firm earned “Buy” rating on Friday, July 31 by Deutsche Bank. As per Monday, August 29, the company rating was maintained by FBR Capital. The firm has “Strong Buy” rating by Raymond James given on Friday, January 22. The firm earned “Buy” rating on Monday, June 27 by Sandler O’Neill. RBC Capital Markets maintained Metlife Inc (NYSE:MET) rating on Tuesday, January 19. RBC Capital Markets has “Outperform” rating and $65.0 price target. The firm has “Neutral” rating by Citigroup given on Tuesday, January 5.
Insitutional Activity: The institutional sentiment increased to 1.04 in Q2 2016. Its up 0.01, from 1.03 in 2016Q1. The ratio increased, as 55 funds sold all Metlife Inc shares owned while 343 reduced positions. 81 funds bought stakes while 334 increased positions. They now own 797.11 million shares or 0.92% less from 804.49 million shares in 2016Q1.
Calvert Invest Inc has invested 0.14% of its portfolio in Metlife Inc (NYSE:MET). Winslow Evans And Crocker has 0% invested in the company for 25,130 shares. Guardian Trust accumulated 0% or 669 shares. Trillium Asset Mngmt Ltd Liability Com holds 0.23% or 89,086 shares in its portfolio. Carret Asset Mgmt Ltd Liability Corp holds 109,964 shares or 0.85% of its portfolio. Savings Bank holds 0.18% of its portfolio in Metlife Inc (NYSE:MET) for 32,526 shares. Jump Trading last reported 21,951 shares in the company. M Holdg Securities has 9,679 shares for 0.2% of their US portfolio. Ibm Retirement Fund has invested 0.18% of its portfolio in Metlife Inc (NYSE:MET). Ferguson Wellman Cap Mngmt holds 0.43% or 258,938 shares in its portfolio. The Kentucky-based Hl Financial Services Ltd has invested 0.01% in Metlife Inc (NYSE:MET). The Massachusetts-based Srb has invested 0.02% in Metlife Inc (NYSE:MET). Ruggie Gp accumulated 10 shares or 0% of the stock. Carlson Cap Limited Partnership owns 724,580 shares or 0.36% of their US portfolio. Banced Corp owns 6,774 shares or 0.6% of their US portfolio.
MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The company has a market cap of $49.24 billion. The Company’s divisions include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). It has a 11.8 P/E ratio. The Company’s Retail segment is organized into two businesses: Life & Other, and Annuities.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.